Durable Delivery System Design for Biosynthetic Blood

The contract seeks the engineering and prototyping of field-deployable delivery systems designed for biosynthetic blood, focusing on pre-filled syringes and IV bags that maintain stability under ambient storage conditions and are optimized for rapid use in austere, resource-limited environments. The systems must ensure shelf stability without refrigeration, enabling reliable transport and deployment in combat or disaster scenarios where cold chain infrastructure is unavailable. Design priorities include robustness, ease of use by non-medical personnel, and compatibility with existing field medical protocols to enable immediate administration. This subcontract, posted by the Defense Advanced Research Projects Agency under the Department of Defense, targets innovation in medical delivery technology with a NAICS code of 326199, indicating non-specific plastic product manufacturing with a focus on advanced biocompatible materials and packaging. Proposals are due by May 19, 2026, and the work is intended to support military medical readiness by enabling the safe, efficient, and scalable distribution of biosynthetic blood products in the most challenging operational conditions. The project emphasizes durability, simplicity, and functionality over conventional hospital-based systems.